Form 4 Filing for Amgen Inc. - Officer/Director Transaction

This filing reports a transaction by Kullman Ellen Jamison, a director at Amgen Inc. The transaction, dated May 19, 2026, involves the acquisition of 665 shares of Common Stock. The shares were acquired at a price of $0.0 per share. Following this transaction, the total number of shares owned by the reporting person is 14,535.9807. The filing indicates that these shares include vested Restricted Stock Units (RSUs) and Dividend Equivalents (DEs) granted under the company's incentive programs. Vested RSUs and DEs are paid in shares of common stock on a one-to-one basis, with potential deferral options for directors.